Bryan Di Menna brings a diverse wealth of knowledge to SenesTech Inc. Throughout his career, he has worked with several Fortune 500 companies such as BASF and dsm-firmenich. As an executive at both companies, Bryan successfully led through challenging market conditions to grow both margin and top line revenue, exceeding targets.

Bryan currently serves as the Chief Revenue Officer and Executive Vice President, designing and executing on the global commercial strategy for SenesTech’s innovative rodent contraceptive products.

Prior to joining SenesTech, Bryan led the sales team for North America at dsm-firmenich, the world's largest nutraceutical manufacturer where he orchestrated a turnaround which led to the best sales year in a decade for the region. At BASF, Bryan held multiple roles from business development, technology and licensing through to executive leadership. Bryan launched a globally recognized rapid innovation process leading to successful commercialization of many new technologies across multiple divisions at BASF.

Bryan holds a bachelor's degree from Rowan University in biological sciences and a master’s degree from Thomas Jefferson University where he conducted extensive rodent research for metastatic cancer models for the early CAR T immunotherapy treatments.